INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE (Q2177181): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
label / itlabel / it
PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE_2790
PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE
label / enlabel / en
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE_2790
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE

Revision as of 09:54, 3 November 2020

Project Q2177181 in Italy
Language Label Description Also known as
English
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE
Project Q2177181 in Italy

    Statements

    0 references
    466,511.11 Euro
    0 references
    933,022.21 Euro
    0 references
    50.0 percent
    0 references
    7 November 2016
    0 references
    31 December 2019
    0 references
    TES PHARMA S.R.L.
    0 references
    0 references
    0 references

    43°7'44.51"N, 12°17'15.79"E
    0 references
    PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE - SETUP DI NUOVI SAGGI BIOCHIMICI E CELLULARI AD-HOC (Italian)
    0 references
    INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METABOLIC DISEASES — SETUP OF NEW BIOCHEMICAL AND AD-HOC BIOASSAYS (English)
    0 references

    Identifiers

    I38I16000160007
    0 references